| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 03/26/2008 | EP1901781A2 Optical imaging contrast agents |
| 03/26/2008 | EP1901780A2 Optical imaging contrast agents |
| 03/26/2008 | EP1901779A2 Measurement of gastric acid secretion |
| 03/26/2008 | EP1901659A2 Contrast agents and methods for preparing contrast agents |
| 03/26/2008 | EP1339373B1 Use of moulding compounds for producing treatment devices |
| 03/26/2008 | EP0714405B1 Therapeutic and diagnostic agents for amyloidosis |
| 03/26/2008 | CN101148511A Method for preparing fluorescent chitosan micro-sphere and application of the same in tracer field |
| 03/25/2008 | US7348419 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications |
| 03/25/2008 | US7348361 Solution for diagnosing or treating tissue pathologies |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7347984 Mammalian agmatinase inhibitory substance |
| 03/25/2008 | CA2385533C Polymer stabilized neuropeptides |
| 03/25/2008 | CA2173319C Radiation sensitization using texaphyrins |
| 03/20/2008 | WO2008033031A2 Mri trackable drug delivery particles, uses and methods thereof |
| 03/20/2008 | WO2008012102A3 Radiodense conjugate |
| 03/20/2008 | WO2008008075A3 Magnetic resonance imaging (mri) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization |
| 03/20/2008 | WO2007135367A3 Screen for inflammatory response molulators |
| 03/20/2008 | WO2007133746A3 Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival |
| 03/20/2008 | WO2007100563A3 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 03/20/2008 | WO2007077531A3 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 03/20/2008 | WO2007065021A3 A predictive tool for hyaluronidase treatment success |
| 03/20/2008 | WO2007042775A3 Conjugates of photosensitisers and antibodies |
| 03/20/2008 | WO2005044224A3 Drug delivery system based on polymer nanoshells |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080069778 Polymer-encapsulated microspheres |
| 03/20/2008 | US20080069777 Conformation Specific Antibodies |
| 03/20/2008 | US20080069776 Use of Brilliant Green in diagnosing with an endoscope; diagnosis of cancer, ulcers without excising the tissue, using confocal endoscope; dye is safe, has good contrast |
| 03/20/2008 | US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 03/20/2008 | US20080069774 Targeting ligand specifically binding to an extracellular component of a cellular system, masking the extracellular component from interacting with a component of the cellular system; thrombotic occlusion and loss of vessel patency at the site of the vascular intervention |
| 03/20/2008 | US20080069773 Novel Sodium Channel |
| 03/20/2008 | US20080069772 Treatment of transformed or infected biological cells |
| 03/20/2008 | US20080069771 Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization |
| 03/20/2008 | DE102006040772A1 Polymermatrix, Verfahren zu deren Herstellung sowie deren Verwendung Polymer matrix, process for their preparation and their use |
| 03/19/2008 | EP1900381A1 Pva particle for use in temporary embolization of blood vessel, process for production thereof, and temporary embolizing agent for blood vessel |
| 03/19/2008 | EP1899363A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 03/19/2008 | EP1898960A1 Compositions containing magnetic iron oxide particles and use of said compositions in magnetic particle imaging |
| 03/19/2008 | EP1898959A1 Compositions containing magnetic iron oxide particles, and use of said compositions in magnetic particle imaging |
| 03/19/2008 | EP1898958A2 Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine |
| 03/19/2008 | EP1519683A4 Solid hydrogel coupling for ultrasound imaging and therapy |
| 03/19/2008 | EP1200137B1 Agent for occluding blood vessels |
| 03/18/2008 | US7346387 Methods for improved selectivity in photo-activation and detection of molecular diagnostic agents |
| 03/18/2008 | US7346384 Method of magnetic resonance investigation of a sample using a nuclear spin polarised MR imaging agent |
| 03/18/2008 | US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7344721 Polypeptide for the treatment of cancer and a method for preparation thereof |
| 03/18/2008 | US7344705 Composition comprising low density microspheres |
| 03/18/2008 | US7344704 Micelle forming concentration; controlling particle sizes;galolinium complex |
| 03/18/2008 | US7344703 Mycobacterial sulfation pathway proteins and methods of use thereof |
| 03/18/2008 | US7344702 Contrast agents for myocardial perfusion imaging |
| 03/18/2008 | US7344699 Drug conjugate comprising an erythropoietin receptor ligand and an anticancer agent |
| 03/18/2008 | US7344698 Emulsion containing nanoparticles in perfluorohydrocarbon solvent; antiinflammatory agents; antitumor agents |
| 03/18/2008 | CA2269319C Improvements in or relating to contrast agents |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/13/2008 | WO2008031038A2 Pre- and intra-operative localization of penile sentinel nodes |
| 03/13/2008 | WO2008029599A1 Magnetic particles and process for their production |
| 03/13/2008 | WO2008028917A1 Gas-filled microvesicles with polymer-modified lipids |
| 03/13/2008 | WO2008000403A3 Method and device for optical detection of the eye |
| 03/13/2008 | US20080064923 Device,System And Method For In-Vivo Anaysis |
| 03/13/2008 | US20080063720 Delivery System |
| 03/13/2008 | US20080063605 administering gadolinium texaphyrin complexes and imaging using magnetic resonance imaging; tissue-targeted therapy; slower pharmacokinetics |
| 03/13/2008 | US20080063604 Method and composition for the site-selective gene delivery using viruses |
| 03/13/2008 | US20080063603 Ultrasound contrast agents and methods of making and using them |
| 03/13/2008 | US20080063602 gadolinium chelating polymers comprising hydroxypyridonate-based chelating moieties integrated into benzonorbornadiene graft polymers, useful for therapy and medical diagnosis |
| 03/13/2008 | US20080063601 treatment of urogenital disorders comprising administering calcium channel blockers, such as triptolide, prodrugs and/or derivatives |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | US20080063599 Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils |
| 03/13/2008 | CA2662087A1 Gas-filled microvesicles with polymer-modified lipids |
| 03/13/2008 | CA2661634A1 Selectively targeted antimicrobial peptides and the use thereof |
| 03/13/2008 | CA2653696A1 Recombinant vaccine against bluetongue virus |
| 03/12/2008 | EP1896846A2 Analysis method for determining a functional parameter of an organ using preferably an aqueous 13c methacetin solution |
| 03/12/2008 | EP1896093A2 Polymeric marker with high radiopacity for use in medical devices |
| 03/12/2008 | EP1896086A1 Hydrazide conjugates as imaging agents |
| 03/12/2008 | EP1896085A1 Peptides whose uptake by cells is controllable |
| 03/12/2008 | EP1895993A1 Electrostatic patch for allergen screening and applicator for same |
| 03/12/2008 | EP1450751B1 Nanoparticle delivery vehicle |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101140274A Insulinogen C peptide biological activity measuring method |
| 03/12/2008 | CN101138638A Composition for determining pyrimidine metabolizing activity |
| 03/12/2008 | CN100374550C Magnetic cell and method of using the same |
| 03/12/2008 | CN100374165C Ultrasound contrast agents and process for the preparation thereof |
| 03/12/2008 | CN100374154C Sincalide formulations |
| 03/11/2008 | US7341832 Genes involved in neuropsychiatric disorders |
| 03/11/2008 | US7341724 Apoptosis of rectum and prostate gland cancer |
| 03/11/2008 | US7341711 Porphyrin compounds and their use in high-field MRI |
| 03/11/2008 | US7341710 Method of identifying molecules that home to a selected organ in vivo |
| 03/11/2008 | CA2451924C Diagnostic agents for pancreatic exocrine function |
| 03/07/2008 | WO2008078424A1 Benzoxazole derivatives |
| 03/06/2008 | WO2008028162A2 Methods of screening agents for activity using teleosts |
| 03/06/2008 | WO2008028140A1 Methods and compositions for increasing patient tolerability during myocardial imaging methods |
| 03/06/2008 | WO2008027611A2 Compositions for visualization of vitreous body and methods of using same |
| 03/06/2008 | WO2008027162A2 129xe biosensors and their use |
| 03/06/2008 | WO2008026937A1 Method of dynamic nuclear polarisation (dnp) and compounds and compositions for use in the method |
| 03/06/2008 | WO2007135368A3 Dye compounds and the use of their labelled conjugates |
| 03/06/2008 | US20080060088 Using transgenic animal model as screening tool in identifying agents for prevention and treatment of psychological disorders |
| 03/06/2008 | US20080058284 Pharmaceutical compositions of semicarbazones and/or thiosemicarbazones and/or their derivatives and products of these compositions and their uses as anticonvulsant, anti-nociceptive and anti-inflammatory agents, and in the angiogenic therapy |
| 03/06/2008 | US20080057001 Contrast agents for imaging |
| 03/06/2008 | US20080057000 Dental compositions having anti-stokes up converters and methods of use |
| 03/06/2008 | US20080056997 preferential binding members against extracellular matrix proteins, especially scFv antibody molecules against peptide domains of the glycoprostien, conjugated with labels, cytotoxic molecules or cytokines, for use in diagnosis and treatment of cancer |
| 03/06/2008 | US20080056996 Photodynamic therapy for the treatment of hair loss |
| 03/06/2008 | US20080056995 System and methods for measuring a skin protection factor |